The Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta offers the largest comprehensive pediatric sickle cell disease program in the country, serving more than 1,700 children with sickle cell disease at three sites in metro Atlanta.
The Aflac Cancer and Blood Disorders Center offers the following services to pediatric sickle cell patients:
- 24-hour acute care
- Health maintenance services
- New patient evaluations
- Patient counseling and sickle cell education
- Newborn screening, follow-up and genetic counseling
- Chronic transfusion services
- Transcranial doppler ultrasound testing for stroke prevention
- Research studies
We are recognized as a national leader in transplanting children with sickle cell disease. Learn more about blood and marrow transplants (BMT), the only cure for sickle cell disease.
In some cases, such as Tendoh’s, a BMT can cure sickle cell disease by replacing the sickle cells with healthy cells from a donor. Meet Tendoh.
Sickle Cell Disease Video
Watch the video to the right to learn more about sickle cell disease in kids, and:
- About our sickle cell disease program
- What is sickle cell disease
- Who is at risk for sickle cell disease
- Effects of sickle cell disease
- How is sickle cell disease treated
- Sickle cell disease at school
Sickle Cell Facilities
The Aflac Cancer and Blood Disorders Center cares for pediatric patients with sickle cell disease and other blood disorders at three hospital locations. All three campuses offer both inpatient and outpatient care for pediatric sickle cell disease patients. Our facilities include:
- Outpatient clinics with a full range of procedural, infusional and apheresis services
- Dedicated diagnostic and laboratory services
- Onsite pharmacy
- 40 inpatient rooms
- HEPA-filtered rooms for inpatient blood and marrow transplant patients
Atlanta Sickle Cell Consortium
Through a city-wide cooperative effort, the Aflac Cancer Center has joined forces with physicians and researchers from Grady Health System, Emory University School of Medicine, Morehouse School of Medicine, Emory Winship Cancer Institute and Georgia Institute of Technology to search for better treatments, prevention and an eventual cure by spearheading and participating in multicenter studies of new treatments, such as hydroxyurea and stem cell transplantation.